Regeneration and characterization of a recombinant bovine viral diarrhea virus and determination of its efficacy to cross the bovine placenta
- PMID: 19067148
- DOI: 10.1007/s11262-008-0308-z
Regeneration and characterization of a recombinant bovine viral diarrhea virus and determination of its efficacy to cross the bovine placenta
Abstract
The capacity of different bovine viral diarrhea virus (BVDV) strains to cause transplacental infection is variable. BVDV strain SD-1 was isolated from a persistently infected heifer. Its genome represents the only reported nucleotide sequence of a noncytopathic viral isolate determined without cell culture passage in the laboratory. Thus, SD-1 might possess biological advantages over other NCP BVDV strains to be used as a model virus for investigation of viral transplacental transmission. To evaluate if a molecularly generated BVDV SD-1 is capable of crossing the bovine placenta efficiently, a full-length cDNA clone of SD-1 was constructed using RT-PCR amplification and standard molecular techniques. In vitro transcripts synthesized from the cDNA template directed the generation of infectious virus in MDBK cells with a transfection efficiency as high as 4.7 x 10(5) FFU/mug RNA. The recovered virus termed ASD1 harbored five silent point mutations engineered as genetic markers and was similar to wild type (wt) SD-1 in viral growth kinetics. As evaluated in the pregnant heifers, ASD1 was capable of crossing the bovine placenta efficiently, suggesting that NCP BVDV SD-1 is a suitable viral backbone for investigation of the role of viral genetic element(s) in viral transplacental transmission by allowing for evaluation of newly created viral mutants.
Similar articles
-
A bovine viral diarrhea virus type 1a strain in China: isolation, identification, and experimental infection in calves.Virol J. 2014 Jan 20;11:8. doi: 10.1186/1743-422X-11-8. Virol J. 2014. PMID: 24444389 Free PMC article.
-
Comparison of reproductive protection against bovine viral diarrhea virus provided by multivalent viral vaccines containing inactivated fractions of bovine viral diarrhea virus 1 and 2.Vaccine. 2018 Jun 18;36(26):3853-3860. doi: 10.1016/j.vaccine.2018.04.005. Epub 2018 Apr 24. Vaccine. 2018. PMID: 29699786 Clinical Trial.
-
Development of fetal and placental innate immune responses during establishment of persistent infection with bovine viral diarrhea virus.Virus Res. 2012 Aug;167(2):329-36. doi: 10.1016/j.virusres.2012.05.018. Epub 2012 May 30. Virus Res. 2012. PMID: 22659490
-
[Bovine diarrhea virus: an update].Rev Argent Microbiol. 1997 Jan-Mar;29(1):47-61. Rev Argent Microbiol. 1997. PMID: 9229725 Review. Spanish.
-
Maternal and fetal response to fetal persistent infection with bovine viral diarrhea virus.Am J Reprod Immunol. 2010 Oct;64(4):295-306. doi: 10.1111/j.1600-0897.2010.00904.x. Epub 2010 Jul 29. Am J Reprod Immunol. 2010. PMID: 20678166 Review.
Cited by
-
An alternative -1/+2 open reading frame exists within viral N(pro)(1-19) region of bovine viral diarrhea virus SD-1.Virus Res. 2012 Jan;163(1):341-51. doi: 10.1016/j.virusres.2011.10.022. Epub 2011 Nov 4. Virus Res. 2012. PMID: 22079882 Free PMC article.
-
The extra 16-amino-acid peptide at C-terminal NS2 of the hypervirulent type-2 bovine viral diarrhea viruses has no effect on viral replication and NS2-3 processing of type-1 virus.Virus Genes. 2010 Oct;41(2):218-23. doi: 10.1007/s11262-010-0503-6. Epub 2010 Jun 30. Virus Genes. 2010. PMID: 20589424
References
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials